156 related articles for article (PubMed ID: 34680961)
1. Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg).
Gilis-Januszewska A; Bogusławska A; Kowalik A; Rzepka E; Soczówka K; Przybylik-Mazurek E; Głowa B; Hubalewska-Dydejczyk A
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680961
[TBL] [Abstract][Full Text] [Related]
2. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
3. Clinical and enzymatic phenotypes in congenital hyperinsulinemic hypoglycemia due to glucokinase-activating mutations: A report of two cases and a brief overview of the literature.
Ping F; Wang Z; Xiao X
J Diabetes Investig; 2019 Nov; 10(6):1454-1462. PubMed ID: 31094068
[TBL] [Abstract][Full Text] [Related]
4. Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.
Challis BG; Harris J; Sleigh A; Isaac I; Orme SM; Seevaratnam N; Dhatariya K; Simpson HL; Semple RK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):855-61. PubMed ID: 24890200
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization.
Martínez R; Gutierrez-Nogués Á; Fernández-Ramos C; Velayos T; Vela A; ; Navas MÁ; Castaño L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):778-783. PubMed ID: 28247534
[TBL] [Abstract][Full Text] [Related]
6. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.
Barbetti F; Cobo-Vuilleumier N; Dionisi-Vici C; Toni S; Ciampalini P; Massa O; Rodriguez-Bada P; Colombo C; Lenzi L; Garcia-Gimeno MA; Bermudez-Silva FJ; Rodriguez de Fonseca F; Banin P; Aledo JC; Baixeras E; Sanz P; Cuesta-Muñoz AL
Mol Endocrinol; 2009 Dec; 23(12):1983-9. PubMed ID: 19884385
[TBL] [Abstract][Full Text] [Related]
7. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
Cuesta-Muñoz AL; Huopio H; Otonkoski T; Gomez-Zumaquero JM; Näntö-Salonen K; Rahier J; López-Enriquez S; García-Gimeno MA; Sanz P; Soriguer FC; Laakso M
Diabetes; 2004 Aug; 53(8):2164-8. PubMed ID: 15277402
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis, treatment and genetic analysis of a case of hypoglycemia caused by glucokinase gene mutation.
Li LY; Liu SQ; Shi Y; Zhao CC; Zhou HW; Zheng XQ
Yi Chuan; 2022 Sep; 44(9):810-818. PubMed ID: 36384957
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous Insulin Receptor
Sethi A; Foulds N; Ehtisham S; Ahmed SH; Houghton J; Colclough K; Didi M; Flanagan SE; Senniappan S
J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):420-426. PubMed ID: 31989990
[TBL] [Abstract][Full Text] [Related]
10. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
Christesen HB; Tribble ND; Molven A; Siddiqui J; Sandal T; Brusgaard K; Ellard S; Njølstad PR; Alm J; Brock Jacobsen B; Hussain K; Gloyn AL
Eur J Endocrinol; 2008 Jul; 159(1):27-34. PubMed ID: 18450771
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
Li C; Juliana CA; Yuan Y; Li M; Lu M; Chen P; Boodhansingh KE; Doliba NM; Bhatti TR; Adzick NS; Stanley CA; De León DD
Diabetes; 2023 Dec; 72(12):1809-1819. PubMed ID: 37725835
[TBL] [Abstract][Full Text] [Related]
12. Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.
Christesen HB; Brusgaard K; Beck Nielsen H; Brock Jacobsen B
Clin Endocrinol (Oxf); 2008 May; 68(5):747-55. PubMed ID: 18208578
[TBL] [Abstract][Full Text] [Related]
13. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic difficulties in glucokinase hyperinsulinism.
Meissner T; Marquard J; Cobo-Vuilleumier N; Maringa M; Rodríguez-Bada P; García-Gimeno MA; Baixeras E; Weber J; Olek K; Sanz P; Mayatepek E; Cuesta-Muñoz AL
Horm Metab Res; 2009 Apr; 41(4):320-6. PubMed ID: 19053014
[TBL] [Abstract][Full Text] [Related]
15. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
16. Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
Roy K; Satapathy AK; Houhton JAL; Flanagan SE; Radha V; Mohan V; Sharma R; Jain V
Indian J Pediatr; 2019 Nov; 86(11):1051-1053. PubMed ID: 31119523
[TBL] [Abstract][Full Text] [Related]
17. A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.
Ünal S; Gönülal D; Uçaktürk A; Siyah Bilgin B; Flanagan SE; Gürbüz F; Tayfun M; Elmaoğulları S; Araslı A; Demirel F; Ellard S; Hussain K
J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):478-481. PubMed ID: 27181099
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
Wabitsch M; Lahr G; Van de Bunt M; Marchant C; Lindner M; von Puttkamer J; Fenneberg A; Debatin KM; Klein R; Ellard S; Clark A; Gloyn AL
Diabet Med; 2007 Dec; 24(12):1393-9. PubMed ID: 17976205
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
Beer NL; van de Bunt M; Colclough K; Lukacs C; Arundel P; Chik CL; Grimsby J; Ellard S; Gloyn AL
J Biol Chem; 2011 May; 286(21):19118-26. PubMed ID: 21454522
[TBL] [Abstract][Full Text] [Related]
20. Ketogenic diet as elective treatment in patients with drug-unresponsive hyperinsulinemic hypoglycemia caused by glucokinase mutations.
Maiorana A; Caviglia S; Greco B; Alfieri P; Cumbo F; Campana C; Bernabei SM; Cusmai R; Mosca A; Dionisi-Vici C
Orphanet J Rare Dis; 2021 Oct; 16(1):424. PubMed ID: 34635134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
